Align Technology, Inc. (ALGN)
Align Technology Q4 Preview: Even After A Big Drop In Price, It's Too Expensive
Align Technology, Inc. is upgraded to Hold after a 30% decline versus SPY's 74% gain over three years. ALGN faces stagnant sales, margin compression, and lackluster growth, with 2025 showing revenue and margin declines. Management guides for sequential improvement in Clear Aligner volume and ASP, with Q4 consensus broadly in line with company expectations.
Here's Why Align Technology (ALGN) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Align Technology: Attractive Entry After Q3 Beat And Multiple Compression
Align Technology (ALGN) is now rated Buy with a $180 target, offering ~10% upside after a significant correction and strong Q3 results. Q3 beat expectations: international demand and children's segment drove higher volumes, though average selling prices declined due to discounts and new markets. Adjusted operating margins improved to 23.9%, with aggressive buybacks and restructuring supporting EPS growth; GAAP margins impacted by one-time charges.
Here's Why Align Technology (ALGN) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ALGN Stock Rises on Thailand Launch of Invisalign With MAOB
Align Technology's Thailand debut of Invisalign with MAOB lifts shares and expands its Class II treatment options for increasing patients.
Align Technology, Inc. (ALGN) Presents at Evercore 8th Annual Healthcare Conference Transcript
Align Technology, Inc. (ALGN) Presents at Evercore 8th Annual Healthcare Conference Transcript
Align Technology, Inc. (ALGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Align Technology, Inc. (ALGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Align Technology (ALGN) Up 6.4% Since Last Earnings Report: Can It Continue?
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
Here's Why Align Technology (ALGN) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Align Technology (ALGN) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Align Technology, Inc. (ALGN) Presents at Jefferies London Healthcare Conference 2025 Transcript
Align Technology, Inc. ( ALGN ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:30 AM EST Company Participants John Morici - CFO & Executive VP of Global Finance Joseph Hogan - President, CEO & Director Presentation Unknown Analyst I'm an analyst on the U.S. Medical Supplies and Devices team, and this is a session for Align Technology. From the company, we've got Joe Hogan, President and CEO; John Morici, CFO; and we've also got Shirley Stacy here as well.
Align Technology, Inc. (ALGN) Presents at UBS Global Healthcare Conference 2025 Transcript
Align Technology, Inc. ( ALGN ) UBS Global Healthcare Conference 2025 November 11, 2025 11:45 AM EST Company Participants John Morici - CFO & Executive VP of Global Finance Conference Call Participants Kevin Caliendo - UBS Investment Bank, Research Division Presentation Kevin Caliendo UBS Investment Bank, Research Division Good afternoon, everybody. I'm Kevin Caliendo, Healthcare IT distribution, Dental Analyst for UBS.
